Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
34 studies found for:    " December 09, 2009":" January 08, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 09, 2009":" January 08, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
2 Active, not recruiting Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
3 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
4 Unknown  Medications for Chronic HIV: Education and Collaboration
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: MedCHEC tablet computer and Adherence Care
5 Completed Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
Condition: HIV Infections
Intervention: Device: In Vitro Diagnostic Device
6 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
7 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
8 Completed Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
Condition: HIV Infection
Interventions: Procedure: GI endoscopy and GALT biopsies;   Biological: A sample of venous blood will also be collected
9 Completed Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
10 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
11 Terminated Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections
Intervention:
12 Active, not recruiting The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Conditions: High Triglyceride Level;   HIV Infection
Intervention: Drug: Lovaza
13 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
14 Completed Isentress Re-examination Study (MK-0518-115)
Conditions: HIV Infection;   HIV Infections
Intervention:
15 Completed Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
16 Completed Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
Condition: HIV-1 Infections
Interventions: Drug: raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine;   Drug: darunavir; ritonavir; emtricitabine/tenofovir
17 Suspended Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Conditions: Sexually Transmitted Infections;   HIV Infections
Intervention:
18 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
19 Recruiting Cohort of HIV Associated Lymphomas
Condition: HIV Infection
Intervention:
20 Completed Accelerated Aging, HIV Infection, Antiretroviral Therapies
Conditions: HIV Infection;   Aging Accelerated;   Antiretroviral Therapies
Intervention: Biological: Peripheral blood biological tests

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years